Fish oil may mitigate cardiovascular risk of impaired fetal growth

Article

Daily fish oil supplementation during the first 5 years of life may reduce the risk of later cardiovascular disease in those with impaired fetal growth.

Daily fish oil supplementation during the first 5 years of life may reduce the risk of later cardiovascular (CV) disease in those with impaired fetal growth, researchers have found in a controlled clinical trial.

Babies with a birth weight below the 90th percentile for their gestational age and sex (n=363) were studied. They were randomized to a 500-mg fish oil supplement daily along with canola-based margarine and cooking oil (omega-3 group) or to a control group that received a sunflower oil supplement and omega-6 fatty acid-rich margarine and cooking oil.

Carotid intima-media thickness (IMT), a surrogate marker of subclinical atherosclerosis, was measured when the children were 8 years old.

Each 1-kg lower birth weight normally translates into a 10% to 20% increased risk of coronary artery disease in adulthood, but the omega-3 supplementation appeared to mitigate this increase in risk. The researchers note that the effect of omega-3 supplementation on carotid IMT is consistent with a potential 5% to 7% reduction in risk of future myocardial infarction and a 6% to 8% reduction in risk of future stroke per kilogram of birth weight.

Compliance with the fish oil capsules was only about 50%, so the true benefit of omega-3 supplementation may be even greater than that observed in this study, they add.

Skilton MR, Aver JG, Harmer JA, et al. Impaired fetal growth and arterial wall thickening: a randomized trial of omega-3 supplementation. Pediatrics. 2012. Epub ahead of print.

Recent Videos
Paul Kruszka, MD
Herbert Bravo, MD
Tina Tan, MD
Paul Kruszka, MD, MPH, FACMG
Stephanie Anne Deutsch, MD, MS, MSCR, FAAP
H. Westley Phillips, MD
David Turkewitz, MD
H. Westley Phillips, MD
David Turkewitz, MD
© 2024 MJH Life Sciences

All rights reserved.